Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | NEU1 | Q99519 | 7/20 | 0.34 |
| ▸ | NANP | Q8TBE9 | 2/20 | 0.34 |
| ▸ | NEU3 | Q9UQ49 | 6/20 | 0.33 |
| ▸ | NEU4 | Q8WWR8 | 6/20 | 0.33 |
| ▸ | NEU2 | Q9Y3R4 | 6/20 | 0.33 |
| ▸ | SELL | P14151 | 1/20 | 0.31 |
| ▸ | SELP | P16109 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15960244 | 1.00 | L3MBTL1 (0.51) | L3MBTL1NEU1NANPNEU3NEU4 | |
| SCHEMBL16865697 | 1.00 | L3MBTL1 (0.51) | L3MBTL1NEU1NANPNEU3NEU4 | |
| SCHEMBL22199276 | 1.00 | L3MBTL1 (0.51) | L3MBTL1NEU1NANPNEU3NEU4 | |
| SCHEMBL16866076 | 1.00 | L3MBTL1 (0.51) | L3MBTL1NEU1NANPNEU3NEU4 | |
| SCHEMBL769321 | 1.00 | L3MBTL1 (0.51) | L3MBTL1NEU1NANPNEU3NEU4 | |
| SCHEMBL18463735 | 0.87 | L3MBTL1 (0.52) | L3MBTL1NEU1NANPNEU3NEU4 | |
| SCHEMBL22022487 | 0.87 | L3MBTL1 (0.52) | L3MBTL1NEU1NANPNEU3NEU4 | |
| SCHEMBL18463646 | 0.85 | L3MBTL1 (0.50) | L3MBTL1NEU1NANPNEU3NEU4 | |
| SCHEMBL22022488 | 0.85 | L3MBTL1 (0.50) | L3MBTL1NEU1NANPNEU3NEU4 | |
| SCHEMBL18934165 | 0.85 | L3MBTL1 (0.50) | L3MBTL1NEU1NANPNEU3NEU4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180163185-A1 | MUTATED SIALIDASES | GLYCOM A/S (DK) | 2018-06-14 | — | — | US | disclosed |
| US-9234225-B2 | Method for generating human milk oligosaccharides (HMOs) or precursors thereof | GLYCOM A/S (DK) | 2016-01-12 | — | — | US | disclosed |
| US-20150183816-A1 | MODIFIED GALACTOOLIGOSACCHARIDES | GLYCOM A/S (DK) | 2015-07-02 | — | — | US | disclosed |
| US-20140234912-A1 | METHOD FOR GENERATING HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF | GLYCOM A/S (DK) | 2014-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180163185-A1 | MUTATED SIALIDASES | NEU4, NEU2, NEU1 | L3MBTL1 381/4885NEU1 3/4885NANP 100/4885 |
| US-20150183816-A1 | MODIFIED GALACTOOLIGOSACCHARIDES | FUT6, GALE, FUT5 | L3MBTL1 2516/4885NEU1 47/4885NANP 100/4885 |
| US-20140234912-A1 | METHOD FOR GENERATING HUMAN MILK OLIGOSACCHARIDES (HMOs) OR PRECURSORS THEREOF | LCT, B4GALT1, GALNT1 | L3MBTL1 460/4885NEU1 63/4885NANP 99/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.